Filtered By:
Drug: Lipitor
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 857 results found since Jan 2013.
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy Effect of Baseline Risk Factors for Diabetes
ConclusionsCompared with lower-dose statin therapy, atorvastatin 80 mg/day did not increase the incidence of NOD in patients with 0 to 1 NOD risk factors but did, by 24%, among patients with 2 to 4 NOD risk factors. The number of CV events was significantly reduced with atorvastatin 80 mg in both NOD risk groups.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - January 7, 2013 Category: Cardiology Source Type: research
Efficacy and safety of intensive statin therapy in the elderly
Am J Geriatr Cardiol. 2008 Mar-Apr;17(2):92-100.ABSTRACTNumerous epidemiologic and intervention trials, including many studying elderly cohorts, have demonstrated the importance of lipids in primary and secondary preventions of cardiovascular diseases, including coronary heart disease (CHD) and stroke. More recent studies have demonstrated that more intensive statin therapy that reduces low-density lipoprotein cholesterol levels to <70 to 80 mg/dL have resulted in more marked cardiovascular event reduction than less intensive statin treatment. The authors review the efficacy and safety of intensive vs less intensive sta...
Source: The American Journal of Geriatric Cardiology - March 11, 2008 Category: Cardiology Authors: Bijesh P Maroo Carl J Lavie Richard V Milani Source Type: research
